SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-08-108316
Filing Date
2008-05-09
Accepted
2008-05-08 21:15:05
Documents
7
Period of Report
2008-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 28277
2 WAIVER AND AMENDMENT AGREEMENT dex43c.htm EX-4.3C 43266
3 WARRANT ISSUED TO KINGSBRIDGE CAPITAL LIMITED dex46a.htm EX-4.6A 53654
4 REGISTRATION RIGHTS AGREEMENT dex46b.htm EX-4.6B 53301
5 COMMON STOCK PURCHASE AGREEMENT dex1070.htm EX-10.70 195786
6 JAZZ PHARMACEUTICALS CODE OF CONDUCT dex141.htm EX-14.1 122028
7 GRAPHIC g83414img001.jpg GRAPHIC 23190
  Complete submission text file 0001193125-08-108316.txt   530143
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 08815780
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1